Market Dynamics
  • Continuing expansion of biopharmaceutical manufacturing capacity by CDMOs/CMOs
  • Increasing outsourcing of biopharmaceuticals-related manufacturing activities
  • Increasing demand for fill-finish services in biopharmaceutical contract manufacturing market
  • Increasing productivity and efficiency of biopharmaceuticals manufacturing processes
  • Uptake of single-use production systems by the biopharmaceutical manufacturing industry
  • Asia emerging as hot destination for biopharmaceutical manufacturing
  • Increasing confidence of pharmaceutical industry in CDMOs capabilities
  • High level of outsourcing of manufacturing newly approved drugs by smaller biotech companies is fueling the growth of biopharma-specific CMOs/CDMOs
  • Higher acceptance and success of biopharmaceutical products in the market provides tremendous opportunities to biopharmaceuticals contract manufacturers
  • Increasing shortage of skilled workforce in the biopharmaceutical industry
  • Expensive manufacturing equipment requirements and complex processes raise barriers to entry, which is limiting market growth
  • Complicated and stringent regulatory requirements hinder market growth

Market Segmentation 2020-2030
Biopharmaceuticals Contract Manufacturing Market is segmented on the Service, Product, and Regional basis.

Service
Process Development
  • Downstream
  • Upstream

Fill & Finish Operations
  • Analytical & Quality Control Studies
  • Packaging

Product

Biologics
  • Monoclonal Antibodies (MAbs)
  • Recombinant Proteins
  • Vaccines
  • Insulin
Biosimilars

Regional Breakdown
Focused regional forecasts and analysis explore the future opportunities:

North America
  • U.S.
  • Canada

Europe
  • UK
  • France
  • Germany
  • Russia
  • Rest of Europe

Asia-Pacific
  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East